Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „Concomitant“
Suchtreffer
Begriffe & Kennungen
CellCept · 4.5 · Isavuconazole An increase of MPA exposure (AUC0-∞) by 35% was observed with concomitant administration of isav
Eintrag öffnenCellCept · 4.5 · Rifampicin In patients not also taking ciclosporin, concomitant administration of mycophenolate mofetil and ri
Eintrag öffnenCellCept · 4.5 · Rifampicin In patients not also taking ciclosporin, concomitant administration of mycophenolate mofetil and ri
Eintrag öffnenCellCept · 4.5 · Telmisartan Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately 3
Eintrag öffnenCellCept · 4.5 · Telmisartan Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately 3
Eintrag öffnenCellCept · 4.5 · Telmisartan Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately 3
Eintrag öffnenCelsentri · 4.5 · 13 St. John’s Wort Co-administration of maraviroc with Concomitant use of (Hypericum Perforatum) St. John's Wo
Eintrag öffnenCelsentri · 4.5 · Concomitant use of CELSENTRI and fosamprenavir/ritonavir is not recommended. Clarithromycin, Not studied, but
Eintrag öffnenCelsentri · 4.5 · Fosamprenavir/ritonavir Maraviroc AUC12: ↑ 2.49 Concomitant use is not 700 mg/100 mg BID Maraviroc Cmax: ↑ 1.5
Eintrag öffnenCerdelga · 4.5 · At 84 mg once daily dosing with eliglustat in PMs, it is predicted that concomitant use of moderate CYP3A inhi
Eintrag öffnenCerdelga · 4.5 · At 84 mg twice daily dosing with eliglustat in non-PMs, it is predicted that concomitant use of moderate CYP2D
Eintrag öffnenCerdelga · 4.5 · At 84 mg twice daily dosing with eliglustat in non-PMs, it is predicted that concomitant use of moderate CYP3A
Eintrag öffnenCerdelga · 4.5 · CYP2D6 inhibitors in IMs and EMs After repeated 84 mg twice daily doses of eliglustat in non-PMs, concomitant
Eintrag öffnenCerdelga · 4.5 · CYP2D6 substrates After a single 50 mg dose of metoprolol, a CYP2D6 substrate, concomitant administration of r
Eintrag öffnenCerdelga · 4.5 · CYP3A inhibitors in IMs and EMs After repeated 84 mg twice daily doses of eliglustat in non-PMs, concomitant a
Eintrag öffnenCerdelga · 4.5 · CYP3A inhibitors in PMs At 84 mg once daily dosing with eliglustat in PMs, it is predicted that concomitant us
Eintrag öffnenCerdelga · 4.5 · Eliglustat is metabolised primarily by CYP2D6 and to a lesser extent by CYP3A4. Concomitant administration of
Eintrag öffnenCerdelga · 4.5 · P-gp substrates After a single 0.25 mg dose of digoxin, a P-gp substrate, concomitant administration of 127 mg
Eintrag öffnenCerdelga · 4.5 · Strong CYP3A inducers After repeated 127 mg twice daily doses of eliglustat in non-PMs, concomitant administra
Eintrag öffnenCervarix · 4.5 · Cervarix may be administered concomitantly with a combined booster vaccine containing diphtheria (d), tetanus
Eintrag öffnen